606526

Pfizer Inc. — FEI 2416101

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 10, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New York, NY (United States)